01_Arterial Blood Gases

Objectives:

1. Interpret ABG results and categorize the abnormal results based on the underlying pulmonary pathophysiology.

2. Define the following terms, appropriately use them, explain the underlying pathophysiology in each and propose treatment for each – hypoxia, hypercapnia, acid-base abnormalities, respiratory alkalosis, and respiratory acidosis.

3. Solve clinical scenarios involving abnormalities of ABG

4. Compare and contrast respiratory acidosis and alkalosis in terms of etiology, pathophysiology, lab findings, and clinical features

5. Compare and contrast metabolic acidosis and alkalosis in terms of etiology, pathophysiology, lab findings and clinical features
		 

02_Pulmonary Function Tests

Objectives:

1. Briefly discuss the normal pulmonary gross anatomy, histology, and physiology

2. List the components of a complete pulmonary function test (PFT) and additional tests that can be added to the standard set.

3. Interpret pulmonary function tests/spirometry results and explain underlying pathophysiology.

4. Interpret spirometry and oximetry results to solve case-based scenarios.

5. Illustrate the indications for pulmonary function testing.
	 

Learning Tasks:

1. List the components of a complete pulmonary function test (PFT).
2. List additional pulmonary function tests which can be added to the standard set.
3. List the indications for PFTs.
4. Review the various volumes recorded on a PFT and interpret spirometry results.
5. Define the following the following terms and interpret abnormal values to explain underlying pathophysiology:
		* FVC
		* FEV1
		* FEV1/FVC
		* FEF 25-75%
		* MVV
		* Peak Flow
		* Diffusion
		* Response to bronchodilators
		* Bronchiolar Challenge
	 
03_Chest X-Ray

Objectives:

1. Briefly discuss the normal pulmonary gross anatomy, histology, and physiology

2. Describe the approach to evaluation of the lungs on chest x-ray.

3. Correlate chest anatomy with chest radiology.

4. Identify an infiltrate, hydropneumothorax, cardiomegaly, pulmonary edema, cavitary lesion of lung, pneumothorax, pleural effusion and atelectasis.

5. Recognize the indications for CT and nuclear studies to evaluate pulmonary diseases.
	 
Learning Tasks

1. Identify the structures seen on a chest x-ray (CXR).
2. Review the anatomy of the chest, thorax, and intrathoracic structures including the lobes, and segments of the lungs.
3. List the indications for a CXR.
4. Describe the abnormal findings on a CXR and relate them to the underlying pathophysiology.
5. Identify the normal mediastinal structures and list pathological findings that can be found in each compartment.
6. Recognize the indications for chest X- rays
7. Recognize an infiltrate on a chest X-ray.
8. Recognize the pneumothorax, pleural effusion, and atelectasis
9. Differentiate pneumothorax from pleural effusion of atelectasis
10. Differentiate atelectasis from pleural effusion.
11. Recognize hydropneumothorax
12. Recognize cardiomegaly and pulmonary edema.
13. Recognize a cavitary lesion of the lung 
	 

04_Hypoxemic & Hypercapneic Respiratory Failure including ARDS

Objectives:

1. Describe signs and symptoms, epidemiology, etiology, genetics, pathology, pathophysiology, pathogenesis, clinical features, diagnostic criteria, laboratory and imaging findings, treatment options, ventilatory strategies used in the management, prognosis, and sequelae of ARDS.

2. Explain and differentiate the causes of respiratory failure based on the mechanism.

3. Discuss indications for mechanical ventilation and complications from ventilator support. Categorize various types of respiratory failure based on historical, exam, laboratory, radiological findings, etiology, and pathophysiology.
	 
Learning Tasks:

1. Differentiate the causes of respiratory failure.
2. Explain changes in pCO 2 and relate those changes to the underlying etiology of a patient in respiratory failure.
3. Describe the relationship of levels of pCO 2 to pH in respiratory failure (acute and chronic).
4. Discuss the causes and effects of changes in dead space.
5. Solve clinical scenarios related to respiratory failure that occur with and without additional associated illnesses and explain the ABG findings.
6. List the causes, explain the etiology, discuss the pathophysiology, and propose management of the following
		* Increased CO 2 production
		* Reduced ventilatory drive
		* Excess mechanical load
		* Respiratory muscle weakness
		* Increased V D
		* Hypercapnic ventilatory failure
		* Failure of oxygenation
		* Shunt
		* V/Q mismatch
		* Recognize the signs and symptoms of ventilatory failure
		* State the Fick Equation and utilize it to solve clinical scenarios.
	 

05_Pulmonary Emboli

Objectives:

1. Describe signs and symptoms, epidemiology, etiology, genetics, pathophysiology, pathogenesis, risk factors, clinical features, diagnostic criteria, laboratory and imaging findings, treatment options, prognosis, prevention, and sequelae of deep venous thrombosis (DVT) and pulmonary emboli (PE).

2. Relate DVT to PE and discuss the risk of PE from DVT.

3. List causes of PE other than thrombi.

4. Solve case-based problems related to DVT and PE based on history, physical exam, imaging, and lab findings, and propose treatment options and complications.

5. Compare and contrast the various types of pulmonary embolism
	 
Learning Tasks:
	
1. Describe signs and symptoms, epidemiology, etiology, genetics, pathology, pathophysiology, pathogenesis, clinical features, diagnostic criteria, laboratory and imaging findings, treatment options, prognosis, prevention, and sequelae of pulmonary emboli (PE).
2. Relate deep venous thrombosis (DVT) to PE and discuss the risk of PE from DVT.
3. List the risk factors for DVT.
4. List other causes of PE other than thrombi.
5. Solve case-based problems related to DVT and PE based on history, physical exam, imaging, and lab findings, and propose treatment options.


06_Pathology of Obstructive Lung Disease

Objectives
	 
1. Compare and contrast obstructive versus restrictive lung diseases and list the major pathophysiologic categories of both types of abnormalities.

2. Compare, contrast, and morphologically identify the following obstructive lung diseases:
	* emphysema
	* centriacinar (centrilobular)
	* panacinar (panlobular)
	* distal acinar (parasepta)
	
	* chronic bronchitis
		* asthma
		* bronchiectasis
	      
3. Compare and contrast the etiology and pathogenesis of the following types of asthma:
	* atopic (allergic)
	* nonatopic (nonallergic, “infectious”)
	* drug-induced
	* occupational
	 
4. Describe the pathogenesis of pulmonary hypertension in the chronic obstructive lung diseases

5. Discuss the following pulmonary congenital anomalies, in terms of morphology and clinical consequences:
	* agenesis
	* hypoplasia
	* congenital lobar overinflation ("emphysema")
	* congenital cyst
	* bronchopulmonary sequestration

6. Discuss the various forms of atelectasis, in terms of predisposing factors and pathogenesis
	 
Resources:

Robbins and Cotran (8th ed.), Chapter 15:
pp. 679-680 [“Congenital Anomalies” and “Atelectasis (Collapse)”]
pp. 683-693 (“Obstructive versus Restrictive Pulmonary Diseases” and Obstructive Pulmonary Diseases")
	 

07_08_Pathophysiology of Obstructive Lung Diseases & Discussion
	
Objectives:

1. Describe signs and symptoms, epidemiology, etiology, genetics, pathology, pathophysiology, pathogenesis, clinical features, diagnostic criteria, laboratory and imaging findings, treatment options, prognosis, and sequelae of asthma.

2. Describe signs and symptoms, epidemiology, etiology, genetics, pathology, pathophysiology, pathogenesis, clinical features, diagnostic criteria, laboratory and imaging findings, treatment options, prognosis, and sequelae of chronic obstructive pulmonary disease.

3. Describe signs and symptoms, epidemiology, etiology, genetics, pathology, pathophysiology, pathogenesis, clinical features, diagnostic criteria, laboratory and imaging findings, treatment options, prognosis, and sequelae of cystic fibrosis.

4. Compare, contrast, and morphologically identify the following obstructive lung diseases:

	* Emphysema: centriacinar (centrilobular), panacinar (panlobular), distal acinar (paraseptal)
	* Chronic bronchitis|asthma|bronchiectasis
	 
Learning Tasks:

1. Define and discuss the GOLD protocol/report.
2. Define COPD.
3. Describe signs and symptoms, epidemiology, etiology, genetics, pathology, pathogenesis, clinical features, diagnostic criteria, laboratory and imaging findings, treatment options, and prognosis of COPD.
4. Differentiate/Distinguish asthma and COPD.
5. Contrast normal and COPD spirometry findings.
6. Categorize COPD based on severity.
7. Discuss risk reduction strategies for patients at risk of or with COPD including smoking cessation strategies.
8. Describe pulmonary rehab therapy for COPD.
	 

09_Pulmonary Pharmacology

Objectives:

1. Describe signs and symptoms, epidemiology, etiology, genetics, pathology, pathophysiology, pathogenesis, clinical features, diagnostic criteria, laboratory and imaging findings, treatment options, prognosis, and sequelae of asthma.

2. Describe signs and symptoms, epidemiology, etiology, genetics, pathology, pathophysiology, pathogenesis, clinical features, diagnostic criteria, laboratory and imaging findings, treatment options, prognosis, and sequelae of chronic obstructive pulmonary disease.
	 

Learning Tasks:

1. Describe bronchodilator medications based on their mode of action, route of administration, characteristics, indications, duration of action, side effects, risk/benefits to use, and contraindications.
2. Classify the bronchodilators into one of the following groups: Methylzanthines, Beta-agonists, Anticholinergics, Antiinflammory agents
			 

10_Pathology of Infiltrative Lung Diseases and Pneumoconioses

Objectives:
	
1. Compare and contrast the following forms of diffuse infiltrative lung disease:

		* idiopathic pulmonary fibrosis (IPF)
		* nonspecific interstitial pneumonia (NSIP)
		* cryptogenic organizing  pneumonia (COP)
		* desquamative interstitial pneumonia (DIP)
		* respiratory bronchiolitis-associated interstitial lung disease (RB-ILD)
	
	in terms of:

		* synonyms
		* associated diseases
		* etiopathogenesis
		* morphologic features
		* prognosis

2. Discuss autoimmune ("collagen-vascular") diseases, acute and chronic radiation-induced lung injury, and drug-induced lung diseases.
		 
3. List the factors upon which the development of a pneumoconiosis depend. Discuss basic pathogenesis, diagnostic criteria, clinical features of the pneumoconioses
		 
4. Compare and contrast:

		* coal workers’ pneumoconiosis
		* silicosis
		* silicatosis
		* mixed dust fibrosis
		* asbestosis
		* berylliosis
		* hard metal pneumoconiosis
		 
5. Compare and contrast the following asbestos-related thoracic diseases:

		* nonneoplastic pleural changes (plaques, effusions, fibrosis, adhesions)
		* asbestosis
	
	in terms of:

		* morphology
		* clinical features
		* relationship to malignancy

6. Discuss the carcinogenic potential of the following substances:

		* coal dust
		* silica
		* asbestos
		* beryllium
		* tobacco smoke
	
	with regard to the relative contributory risk for the development of:
		
		* lung carcinoma
		* malignant mesothelioma

7. Describe the etiopathogenesis, morphologic features, associated conditions, and prognosis of each of the following disorders:
			
		* sarcoidosis
		* hypersensitivity pneumonitis (HP)
		* pulmonary eosinophilic syndromes
		* pulmonary alveolar (lipo)proteinosis (PAP)
		 
8. List the roles and guidelines of a physician as a medicolegal consultant in occupational medicine cases. List the guidelines for ascription of etiology with regard to a given agent in a case of a given disease
	 
Resources:
Robbins and Cotran (8 th ed.), pp. 693-706: ["Chronic Diffuse Interstitial (Restrictive) Diseases"]


11_12_Interstitial Lung Disease & Discussion

Objectives:

1. Describe signs and symptoms, epidemiology, etiology, genetics, pathology, pathophysiology, pathogenesis, clinical features, diagnostic criteria, laboratory and imaging findings, treatment options, prognosis, and sequelae of restrictive lung disease (including interstitial lung disease - ILD)

Learning Tasks:

1. Define interstitial lung disease (ILD).
2. Describe signs and symptoms, epidemiology, etiology, genetics, pathology, pathophysiology, pathogenesis, clinical features, diagnostic criteria, laboratory and imaging findings, treatment options, prognosis, and sequelae of ILD.
3. Describe the classification of ILD and apply the classification to a case presentation.
4. List the various types of ILD and discuss the underlying cause if known.
5. Discuss the formation and outline the various causes of granuloma.
6. Describe the evaluation of a patient with suspected ILD and recognize the findings for each investigation.
7. Solve case-based problems related to ILD based on history, physical exam, imaging, and lab findings.


13_Pathology of the Upper Respiratory Tract

Objectives:

1. Distinguish between the various bacterial, viral, and fungal infections of the head and neck based on clinical and morphologic features, epidemiology, etiology, and pathogenesis.

2. Describe the development of head and neck squamous cell carcinoma in terms of clinical, histologic, and molecular progression.

3. Distinguish between inflammatory and necrotizing lesions of the nose, nasopharynx, and larynx based on etiology, clinical manifestations, and clinical course.

4. Compare and contrast the benign and malignant tumors of the nose, sinuses, nasopharynx, and larynx in terms of risk factors, morphology, and clinical course.

Resources:
Robbins & Cotran (8th ed.), Chapter 16,
		pp. 745-748 (“SQUAMOUS CELL CARCINOMA”)
		pp. 749 – 754 (“UPPER AIRWAYS” and “EARS”)


14_Upper Respiratory Tract Physiology & Disease

Objectives:

1. Describe the clinical presentation and epidemiology of rhinitis.

2. List the major viral causes of rhinitis and describe the characteristics and mechanisms of attachment of each and how they are spread. These include: rhinoviruses and coronaviruses.

3. Describe the treatment recommended for rhinitis.

4. Describe the clinical presentation and epidemiology of sinusitis.

5. List the major bacterial causes of sinusitis and describe the characteristics, mechanisms of pathogenesis and physiology of each. These include: Streptococcus pneumoniae, Haemophilus influenza, Morexella catarrhalis.

6. Describe the basic treatment options for sinusitis depending on the etiology. Discuss the prevalence and mechanisms of antimicrobial resistance.

7. Interpret the clinical and laboratory findings that lead to differential diagnosis for sinusitis.

8. Describe the clinical presentation and epidemiology of pharyngitis.

9. List the major viral and bacterial causes of pharyngitis and describe the characteristics, mechanisms of pathogenesis and physiology of each. These include: rhinoviruses, adenoviruses, caronoviruses, Epstein Barr virus, Streptococcus pygenes, Corynebacterium diphtheria, and Neiseria gonorrhea. 

10. Interpret the clinical and laboratory findings that lead to differential diagnosis for pharyngitis.

11. Describe the basic treatment options for pharyngitis depending on the etiology. Discuss the prevalence and mechanisms of antimicrobial resistance. 

12. Distinguish between inflammatory and necrotizing lesions of the nose, nasopharynx, and larynx based on etiology, clinical manifestations, and clinical course.

13. The student will be able to describe the mechanisms by which the following pulmonary defense mechanisms accomplish their functions: nasal clearance, laryngeal (including epiglottic) action, tracheobronchial clearance, alveolar clearance.

14. The student will be able to list the signs, symptoms, and usual etiology of acute epiglottitis.


15_Path of Pulmonary Vascular Diseases

Objectives:

1. Enumerate and explain the etiologies, pathogenesis/mechanisms, morphology, and complications of hemodynamic pulmonary congestion and edema, as well as acute (adult) respiratory distress syndrome (ARDS) and neonatal respiratory distess syndrom (NRDS).

2. Describe pulmonary embolism, infarction, and hypertension in terms of epidemiology, predisposing conditions, pathogenesis, pathophysiologic response, morphology, and clinical course.

3. Compare and contrast the following diffuse pulmonary hemorrhage syndromes:
	
		* Goodpasture syndrome
		* Idiopathic pulmonary hemorrhage (hemosiderosis)
		* Vasculitis-associated pulmonary hemorrhage

4. Compare and contrast primary and secondary pulmonary hypertension, and contrast the lesions seen in reversible pulmonary hypertension with those seen in irreversible pulmonary hypertension.

Learning Task:

Define and use in proper context:

		* acute (adult) respiratory distress syndrome (ARDS)                                
		* acute interstitial pneumonia (AIP)
		* acute lung injury (ALI)
		* angiomatoid lesion
		* bone morphogenetic protein receptor type 2 (BMPR2)
		* brown induration
		* capillaritis
		* cardiogenic pulmonary edema
		* cor pulmonale
		* diffuse alveolar damage (DAD)
		* diffuse alveolar hemorrhage (DAH)
		* electromechanical dissociation
		* Hamman-Rich syndrome
		* "heart failure cells"
		* hemodynamic pulmonary edema
		* hyaline membrane
		* hypostatic pneumonia
		* noncardiogenic pulmonary edema                                                                     
		* plexiform lesion
		* plexogenic pulmonary arteriopathy
		* pulmonary arterial hypertension (PAH)  
		* pulmonary hypertension (PH)
		* "saddle embolus"
		* "shock lung"

Resources:
Robbins & Cotran (8th ed.), Chapter 15:
		pp. 680-683 [“Pulmonary Edema”, “Acute Lung Injury and Acute Respiratory Distress Syndrome (Diffuse Alveolar Damage)”]
		pp. 706-710 (“Diseases of Vascular Origin”)


16_Pulmonary Q&A

Objectives:

1. This will be a review of covered topics and and an opportunity for students to ask specific questions.  Please refer to the objectives for respiratory topics already covered.


17_TB & TB Drugs

Objectives:

1. Differentiate among tuberculosis, sarcoidosis, and granulomatous fungal disease.

2. Describe the differences in the clinical findings in primary, secondary, and miliary tuberculosis.

3. Explain how the immune mechanisms vary between primary and secondary tuberculosis.

4. Describe the virulence and host factors which are operative in tuberculosis.

5. Describe the epidemiology and pathology associated with pulmonary tuberculosis and distinguish between primary vs. secondary (reactivation) disease

6. Differentiate among tuberculosis, sarcoidosis, and granulomatous fungal disease

7. The student will be able to discuss the following specific respiratory tract infections: anthrax, Legionnaire's disease, actinomycosis, nocardiosis, tuberculosis, atypical mycobacteriosis, mycoplasma pneumonia, psittacosis, histoplasmosis, coccidioidomycosis, blastomycosis, crytococossis, aspergillosis, mucormycosis, respiratory syncytial virus (RSV) infection, influenza pneumonia, adenovirus pneumonia, cytomegalic inclusion disease (CID), severe acute respiratory syndrome (SARS), Pneumocystis jereveci (carinii) pneumonia (PCP), toxoplasmosis, strongyloidiasis, in terms of: characteristics of organism, predisposing factors, associated conditions, pathogenesis, morphology (including use of special stains), radiologic features, clinical features, prognosis, 28. Differentiate among tuberculosis, sarcoidosis, and granulomatous fungal disease on the basis of: etiopathogenesis, morphologic features, including use of special stains, organs involved, radiologic features, clinical presentation, diagnostic tests, laboratory findings, prognosis.

8. Describe the mechanisms of action of the major drugs for treating mycobacterial infections including tuberculosis and leprosy.

9. Describe the mechanisms of action of the major drugs for treating mycobacterial infections. 

10. Describe the mechanisms underlying the resistance to the major drugs for treating mycobacterial infections.

11. Describe the treatment regimens for tuberculosis and leprosy.

12. Recognize the adverse effects and drug interaction of the major drugs for treating mycobacterial infections. 


18_Pathology of Pulmonary Infections

Objectives:

1. Describe the mechanisms by which pulmonary defense mechanisms accomplish their functions and describe the pathologic processes which may circumvent them, leading to pulmonary infections

2. Compare and contrast:

		* bronchopneumonia
		* lobar pneumonia
		* interstitial pneumonia
		* aspiration pneumonia
		* lung abscess
		* lipid pneumonia
		* pulmonary infiltrates in the immunocompromised host

3. Discuss the following specific respiratory tract infections:

		* respiratory syncytial virus (RSV)infection
		* influenza pneumonia|adenovirus pneumonia
		* cytomegalovirus pneumonia
		* mycoplasma pneumonia
		* Legionnaire's disease
		* actinomycosis
		* nocardiosis
		* Pneumocystis jiroveci(carinii)pneumonia
		* aspergillosis
		* mucormycosis
		* tuberculosis
		* histoplasmosis
		* cryptococossis
		* coccidioidomycosis
		*blastomycosis

	in terms of:
		characteristics of organism, predisposing factors, associated conditions, pathogenesis, morphology, including use of special stains, radiologic features, clinical features, prognosis

4. Differentiate among tuberculosis, sarcoidosis, and granulomatous fungal disease.

Resources:
Robbins & Cotran 8th. Edition; pp. 339, 366-372, 710-720.


19_Upper Respiratory Tract Infections/Pneumonias

Objectives:

1. Describe the innate mechanisms that protect the upper respiratory system from infection, including anatomy, physiology, immune responses, and normal flora. 

2. Describe the clinical presentation and epidemiology of rhinitis.
		* List the major viral causes of rhinitis and describe the characteristics and mechanisms of attachment of each and how they are spread. These include: rhinoviruses and coronaviruses.
		* Describe the treatment recommended for rhinitis.

3. List the major bacterial and viral causes of bronchitis and describe the characteristics, mechanisms of pathogenesis and physiology of each. These include: Bordetella pertussis, Mycoplasma pneumoniae, Chlamydophila pneumoniae, Influenza virus, Adenovirus, and Respiratory syncitial virus (RSV).

4. Describe the clinical presentation and epidemiology of pharyngitis.
		* List the major viral and bacterial causes of pharyngitis and describe the characteristics, mechanisms of pathogenesis and physiology of each. These include: rhinoviruses, adenoviruses, caronoviruses, Epstein Barr virus, Streptococcus pygenes, Corynebacterium diphtheria, and Neiseria gonorrhea. 
		* Interpret the clinical and laboratory findings that lead to differential diagnosis for pharyngitis.
		* Describe the basic treatment options for pharyngitis depending on the etiology. Discuss the prevalence and mechanisms of antimicrobial resistance. 

5. Describe the clinical presentation and epidemiology of bronchitis.
		* Interpret the clinical and laboratory findings that lead to differential diagnosis for bronchitis.
		* Describe the basic treatment options for bronchitis depending on the etiology. Discuss the prevalence and mechanisms of antimicrobial resistance.

6. Describe the clinical presentation and epidemiology of bronchiolitis.
		* List the major bacterial and viral causes of bronchiolitis and describe the characteristics, mechanisms of pathogenesis and physiology of each. These include: Bordetella pertussis, Mycoplasma pneumoniae, and Respiratory syncitial virus (RSV). 
		* Interpret the clinical and laboratory findings that lead to differential diagnosis for bronchiolitis.
		* Describe the basic treatment options for bronchiolitis depending on the etiology. Discuss the prevalence and mechanisms of antimicrobial resistance. 

7. Describe the clinical presentation and epidemiology of sinusitis.
		* List the major bacterial causes of sinusitis and describe the characteristics, mechanisms of pathogenesis and physiology of each. These include: Streptococcus pneumoniae, Haemophilus influenza, Morexella catarrhalis.
		* Interpret the clinical and laboratory findings that lead to differential diagnosis for sinusitis.
		* Describe the basic treatment options for sinusitis depending on the etiology. Discuss the prevalence and mechanisms of antimicrobial resistance.

8. Identify the factors that predispose a patient to pneumonia.
		*Describe the clinical presentation and epidemiology of pneumonia.
		* List the major bacterial, fungal, and viral causes of pneumonia and describe the characteristics, mechanisms of pathogenesis and physiology of each. These include: Streptococcus pneumoniae, Legionella pneumoniae, Mycoplasma pneumoniae, Mycobacterium tuberculosis, Bacillus anthracis, Chlamydia psittaci, Rickettsia, Coxiella burnetti, Klebsiella, Pseudomonas (COPD, cystic fibrosis), Histoplasma capsulatum, Coccidioides immitis, Pneumocystis jiroveci, Blastomyces dermatitidis, Respiratory syncytial virus (RSV), Influenza virus, Severe Acute Respiratory Syndrome Coronavirus, Human metapneumovirus, Bunyaviridae (Hantavirus pulmonary syndrome), and Adenovirus.
		* Interpret the clinical and laboratory findings that lead to differential diagnosis for pneumonia.
		* Describe the basic treatment options for pneumonia depending on the etiology. Discuss the prevalence and mechanisms of antimicrobial resistance. 


20_Pathology of Lung Neoplasms

Objectives:

1. Compare and contrast the following thoracic tumors:
			* squamous cell carcinoma of lung
			* primary adenocarcinoma of lung
			* bronchioloalveolar carcinoma
			* small cell carcinoma of lung
			* large cell carcinoma of lung
			* bronchial carcinoid
			* pulmonary hamartoma|metastatic malignancy to lung & pleura
			* solitary (localized) fibrous tumor of pleura
			* malignant mesothelioma of pleura
	
	in terms of epidemiology, etiology, pathogenesis, molecular biology, morphologic features, radiologic features, clinical manifestations (pulmonary, extrapulmonary), staging|treatment, prognosis.

2. Enumerate the different types of mediastinal masses based on location in:
		* superior mediastinum
		* anterior mediastinum
		* posterior mediastinum
		* middle mediastinum

3. Briefly discuss the diagnostic modalities used to diagnose pulmonary neoplasia

4. Discuss the carcinogenic potential of the following substances:
		* coal dust
		* silica
		* asbestos
		* beryllium
		* tobacco smoke
	
	with regard to the relative contributory risk for the development of:
		* lung carcinoma
		* malignant mesothelioma

5. List the roles and guidelines of a physician as a medicolegal consultant in occupational medicine cases.

6. List the guidelines for ascription of etiology with regard to a given agent in a case of a given disease

Resources:
Robbins & Cotran, 8th Edition: Chapter 15, pp. 721-734 ("Tumors" and "Pleura")


21_Lung Cancer

Objectives:

1. Describe signs and symptoms, epidemiology, etiology, genetics, pathology, pathophysiology, pathogenesis, clinical features, diagnostic criteria, laboratory and imaging findings, treatment options, prognosis, prevention, screening, and sequelae of lung cancer.


22_23_Pleural Disease & Case Studies

Objectives:

1. Discuss pleural effusions on the basis of gross, microscopic, and chemical characteristics, as well as diseases commonly associated with various characteristics.

		* Describe the pathogenesis and categories of pleural effusions.

3. Differentiate asymptomatic, symptomatic, and tension pneumothorax, hemothorax, and pneumomediastinum based on signs, symptoms, clinical presentation, imaging findings, cause, and treatment.

4. Interpret ABG results and categorize the abnormal results based on the underlying pulmonary pathophysiology.

		* Define the following terms, appropriately use them, explain the underlying pathophysiology in each and propose treatment for each – hypoxia, hypercapnia, acid-base abnormalities, respiratory alkalosis, and respiratory acidosis.
		* Solve clinical scenarios involving abnormalities of ABG

5. List the components of a complete pulmonary function test (PFT) and additional tests that can be added to the standard set.
		* Interpret pulmonary function tests/spirometry results and explain underlying pathophysiology.
		* Interpret spirometry and oximetry results to solve case-based scenarios.
		* Illustrate the indications for pulmonary function testing.

6. Describe the approach to evaluation of the lungs on chest x-ray.
		* Correlate chest anatomy with chest radiology.
		* Identify an infiltrate, hydropneumothorax, cardiomegaly, pulmonary edema, cavitary lesion of lung, pneumothorax, pleural effusion and atelectasis.

7. Recognize the indications for CT and nuclear studies to evaluate pulmonary diseases.

8. Discuss the changes that occur in the control of breathing during normal sleep and how these changes impact gas exchange, breathing pattern, and airway resistance.
		* Discuss the roles of chemo- and mechano-receptors in controlling breathing, and how breathing homeostasis is maintained.
		* Describe signs and symptoms, epidemiology, etiology, clinical features, sequalae, and treatment of sleep disorders including obstructive sleep apnea (OSA), central sleep apnea, and restless leg syndrome (RLS).
		* Describe signs and symptoms, epidemiology, etiology, clinical features, sequalae, and treatment of narcolepsy.

9. Describe signs and symptoms, epidemiology, etiology, genetics, pathophysiology, pathogenesis, risk factors, clinical features, diagnostic criteria, laboratory and imaging findings, treatment options, prognosis, prevention, and sequelae of deep venous thrombosis (DVT) and pulmonary emboli (PE).
		* Relate DVT to PE and discuss the risk of PE from DVT.
		* List causes of PE other than thrombi.
		* Solve case-based problems related to DVT and PE based on history, physical exam, imaging, and lab findings, and propose treatment options and complications.

10. Describe signs and symptoms, epidemiology, etiology, genetics, pathology, pathophysiology, pathogenesis, clinical features, diagnostic criteria, laboratory and imaging findings, treatment options, ventilatory strategies used in the management, prognosis, and sequelae of ARDS.

11. Describe the following in terms of epidemiology, etiology, clinical presentation, lab and imaging findings, management, and prognosis - respiratory distress syndrome of the newborn, transient tachypnea of the newborn, pneumonia in the newborn, and pneumothorax in the newborn.

12. Explain and differentiate the causes of respiratory failure based on the mechanism.
		* Discuss indications for mechanical ventilation and complications from ventilator support. Categorize various types of respiratory failure based on historical, exam, laboratory, radiological findings, etiology, and pathophysiology.

13. Describe signs and symptoms, epidemiology, etiology, genetics, pathology, pathophysiology, pathogenesis, clinical features, diagnostic criteria, laboratory and imaging findings, treatment options, prognosis, and sequelae of asthma.

14. Describe signs and symptoms, epidemiology, etiology, genetics, pathology, pathophysiology, pathogenesis, clinical features, diagnostic criteria, laboratory and imaging findings, treatment options, prognosis, and sequelae of chronic obstructive pulmonary disease.

15. Describe signs and symptoms, epidemiology, etiology, genetics, pathology, pathophysiology, pathogenesis, clinical features, diagnostic criteria, laboratory and imaging findings, treatment options, prognosis, and sequelae of cystic fibrosis.

16. Describe signs and symptoms, epidemiology, etiology, genetics, pathology, pathophysiology, pathogenesis, clinical features, diagnostic criteria, laboratory and imaging findings, treatment options, prognosis, and sequelae of restrictive lung disease (including interstitial lung disease - ILD).

17. Describe signs and symptoms, epidemiology, etiology, genetics, pathology, pathophysiology, pathogenesis, clinical features, diagnostic criteria, laboratory and imaging findings, treatment options, prognosis, prevention, screening, and sequelae of lung cancer.

18. Describe the pathogenesis and categories of pleural effusions.

19. Differentiate asymptomatic, symptomatic, and tension pneumothorax, hemothorax, and pneumomediastinum based on signs, symptoms, clinical presentation, imaging findings, cause, and treatment.


24_Pulm Path Lab

Objectives:

1. Describe (where applicable) the etiology, pathogenesis, gross appearance, and key clinical and histologic characteristics of the following, and be able to identify them on microscopic examination:

		* Lung: chronic passive congestion
		* Pulmonary hemorrhage and edema
		* Hemorrhagic pulmonary infarct
		* Neonatal respiratory distress syndrome
		* Adult acute respiratory distress syndrome (ARDS)
		* Bronchial asthma
		* Emphysema
		* Lung: sarcoidosis
		* Pulmonary tuberculosis
		* Pneumonia: bacterial, interstitial (atypical), lipid
		* Bronchial carcinoid
		* Bronchiloalveolar carcinoma (adenocarcinoma) of the lung
		* Squamous cell carcinoma of the lung
		* Large cell (anaplastic) carcinoma of the lung
		* Small cell carcinoma of the lung, metastatic to hilar lymph node

2. Discuss the various forms of atelectasis, in terms of predisposing factors and pathogenesis

3. List likely etiologies and expected effects on pulmonary function of: hydrothorax, empyema, hemothorax, chylothorax, pneumothorax, tension pneumothorax, pleural adhesion.

4. Describe the indications and complications of pulmonary transplantation.


25_Respiratory Emergencies

Objectives:

1. Identify an infiltrate, hydropneumothorax, cardiomegaly, pulmonary edema, cavitary lesion of lung, pneumothorax, pleural effusion and atelectasis.

2. Describe signs and symptoms, epidemiology, etiology, genetics, pathophysiology, pathogenesis, risk factors, clinical features, diagnostic criteria, laboratory and imaging findings, treatment options, prognosis, prevention, and sequelae of deep venous thrombosis (DVT) and pulmonary emboli (PE).

3. Solve case-based problems related to DVT and PE based on history, physical exam, imaging, and lab findings, and propose treatment options and complications.

4. Describe signs and symptoms, epidemiology, etiology, genetics, pathology, pathophysiology, pathogenesis, clinical features, diagnostic criteria, laboratory and imaging findings, treatment options, ventilatory strategies used in the management, prognosis, and sequelae of ARDS.

5. Compare and contrast respiratory acidosis and alkalosis in terms of etiology, pathophysiology, lab findings, and clinical features

6. Compare and contrast metabolic acidosis and alkalosis in terms of etiology, pathophysiology, lab findings and clinical features

7. Discuss various types of electrolyte disorders involving sodium, potassium, chloride, calcium, magnesium, and bicarbonate
